Israeli Biotech Files Ch. 15 To Implement Take-Private Deal
By Vince Sullivan · April 23, 2024, 6:16 PM EDT
Gamida Cell Ltd., an Israeli biotechnology company developing immunotherapy products, filed for Chapter 15 protection Monday in Delaware seeking the American court's approval of its foreign take-private proposal with unsecured lenders....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login